Clinical Trial
doi: 10.1055/s-2007-1002640.
Advantages of low molecular weight heparin over standard heparin: facts and fiction
Affiliations
- PMID: 1666459
- DOI: 10.1055/s-2007-1002640
Item in Clipboard
Clinical Trial
Advantages of low molecular weight heparin over standard heparin: facts and fiction
Semin Thromb Hemost.
1991 Oct.
No abstract available
Similar articles
-
Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.Thromb Haemost. 1994 Dec;72(6):862-8. Thromb Haemost. 1994. PMID: 7740455
-
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.Thromb Haemost. 1995 Mar;73(3):398-401. Thromb Haemost. 1995. PMID: 7667822 Clinical Trial.
-
In vitro protamine neutralization profiles of heparins differing in source and molecular weight.Semin Thromb Hemost. 1989 Oct;15(4):386-9. doi: 10.1055/s-2007-1002735. Semin Thromb Hemost. 1989. PMID: 2554498 No abstract available.
-
Mode of action of heparin and related drugs.Semin Thromb Hemost. 1991;17 Suppl 1:29-34. Semin Thromb Hemost. 1991. PMID: 1648791 Review. No abstract available.
-
Low molecular weight heparins--state-of-the-art and unsolved issues.Blood Coagul Fibrinolysis. 1993 Dec;4 Suppl 1:S17-9. Blood Coagul Fibrinolysis. 1993. PMID: 8180324 Review.
Cited by
-
Efficacy and tolerability of a very low molecular weight heparin compared with standard heparin in patients with unstable angina: a pilot study.Clin Cardiol. 1999 Mar;22(3):213-7. doi: 10.1002/clc.4960220310. Clin Cardiol. 1999. PMID: 10084064 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
